Acurx Pharmaceuticals, Inc. (ACXP) vs CNS Pharmaceuticals, Inc. (CNSP)
Acurx Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($7.6M and $7.5M). Across the 8 metrics below, CNS Pharmaceuticals, Inc. leads on 5 and Acurx Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ACXP | CNSP | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (128.11%) | (106.62%) | (57.72%) |
| Return on assets | (87.57%) | (91.64%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack